7-Oxo-2,4-dimethyl-5,6,7,8-tetrahydro-pyrido<2,3-d>pyrimidin | 145733-63-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶并嘧啶类
• 英文名称: 7-Oxo-2,4-dimethyl-5,6,7,8-tetrahydro-pyrido<2,3-d>pyrimidin
• 英文别名: 2,4-dimethyl-5,8-dihydro-6H-pyrido[2,3-d]pyrimidin-7-one；2,4-dimethyl-5,6,8-trihydro-7H-pyrido[2,3-d]pyrimidin-7-one；2,4-Dimethyl-5,6-dihydropyrido[2,3-d]pyrimidin-7(8H)-one；2,4-dimethyl-6,8-dihydro-5H-pyrido[2,3-d]pyrimidin-7-one
• CAS: 145733-63-7
• 化学式: C₉H₁₁N₃O
• 分子量: 177.206
• InChiKey: CXVCPPQCXTUFQC-UHFFFAOYSA-N

物化性质

• 沸点：
  308.3±35.0 °C(Predicted)
• 密度：
  1.36±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  54.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-Oxo-2,4-dimethyl-5,6,7,8-tetrahydro-pyrido<2,3-d>pyrimidin 在 碘代三甲硅烷 、 sodium hydride 作用下， 以 二氯甲烷 为溶剂， 反应 42.5h， 生成 4'-<(2,4-dimethyl-7-oxo-6,7-dihydro-5H-pyrido<2,3-d>pyrimidin-8-yl)methyl>biphenyl-2-carboxylic acid
  参考文献：
  名称：

  Pyrido[2,3-d]pyrimidine Angiotensin II Antagonists

  摘要：

  A series of pyrido[2,3-d]pyrimidine angiotensin II (A II) antagonists was synthesized and tested for antagonism of A II. Compounds with a biphenylyltetrazole pharmacophore and small alkyl groups at the 2- and ii-positions Of the pyridopyrimidine ring were found to be the most potent in an AT(1) receptor binding assay and in blocking the A II presser response in anesthetized, ganglion-blocked A II-infused rats. 5,8-Dihydro-2,4-dimethyl-8-[(2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl)methyl] pyrido[2,3-d]pyrimidin-7(6H)-one (4a) was one of the more potent compounds in the binding assay and was the most efficacious compound in the A II-infused rat model. Further study of 4a;in Goldblatt (2K-1C) rats showed the compound to have oral bioavailability and to be an efficacious and potent compound in a high renin form of hypertension.

  DOI：

  10.1021/jm00030a013
• 作为产物：
  描述：

  ethyl 3-(4-chloro-2,6-dimethylpyrimidin-5-yl)propionate 在 氨 作用下， 以 乙醇 、 水 为溶剂， 以14.9 g (76%)的产率得到7-Oxo-2,4-dimethyl-5,6,7,8-tetrahydro-pyrido<2,3-d>pyrimidin
  参考文献：
  名称：

  Substituted pyridopyrimidines useful as antgiotensin II antagonists

  摘要：

  本发明涉及一般式I的吡咯基、吡啶基、氮杂七元环和氮杂环丙嘧啶类化合物，对治疗高血压和充血性心力衰竭有用，还涉及制药组合物及其生产方法。

  公开号：

  US05149699A1

文献信息

• Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
  申请人：GlaxoSmithKline Intellectual Property Development Limited

  公开号：US10702521B2

  公开（公告）日：2020-07-07

  The present invention relates to methods for treating Neisseria Gonorrhoeae infection which comprises administering to a subject in need thereof novel 1,2-dihydro-2a,5,8a-triazaacenaphthylene-3,8-dione compounds: or pharmaceutically acceptable salts thereof and/or corresponding pharmaceutical compositions.

  本发明涉及治疗淋病双球菌感染的方法，包括向需要的受试者施用新型1,2-二氢-2a,5,8a-三氮杂蒽-3,8-二酮化合物：或其药学上可接受的盐和/或相应的药物组合物。
• Substituted pyridopyrimidines useful as antgiotensin II antagonists
  申请人：American Home Products Corporation

  公开号：US05149699A1

  公开（公告）日：1992-09-22

  This invention relates to pyrrolo-, pyrido-, azepino-, and azocinopyrimidines of the general formula I ##STR1## useful for treating hypertension and congestive heart failure, to pharmaceutical compositions, and to methods for production thereof.

  本发明涉及一般式I的吡咯基、吡啶基、氮杂七元环和氮杂环丙嘧啶类化合物，对治疗高血压和充血性心力衰竭有用，还涉及制药组合物及其生产方法。
• [EN] TRICYCLIC NITROGEN COMPOUNDS USED AS ANTIBACTERIALS<br/>[FR] COMPOSÉS AZOTÉS TRICYCLIQUES UTILISÉS COMME AGENTS ANTIBACTÉRIENS
  申请人：GLAXO GROUP LTD

  公开号：WO2010043714A1

  公开（公告）日：2010-04-22

  Tricyclic nitrogen containing compounds (I) and their use as antibacterials.

  三环氮含有化合物（I）及其作为抗菌剂的用途。
• [EN] TRICYCLIC NITROGEN CONTAINING COMPOUNDS FOR TREATING NEISSERIA GONORRHOEA INFECTION<br/>[FR] COMPOSÉS CONTENANT DE L'AZOTE TRICYCLIQUE POUR LE TRAITEMENT DE L'INFECTION À NEISSERIA GONORRHOEAE
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2016027249A1

  公开（公告）日：2016-02-25

  The present invention relates to methods for treating Neisseria gonorrhoeae infection which comprises administering to a subject in need thereof novel Tricyclic nitrogen containing compounds and corresponding pharmaceutical compositions as described herein.

  本发明涉及一种治疗淋病奈瑟氏菌感染的方法，包括向需要该方法的受试者施用本文所述的新型三环氮含量化合物及相应的药物组成。
• Condensed pyrimidine derivatives and their use as angiotensine II antagonists
  申请人：AMERICAN HOME PRODUCTS CORPORATION

  公开号：EP0539086A2

  公开（公告）日：1993-04-28

  This invention relates to pyrrolo-, pyrido-, azepino-, and azocinopyrimidines of the general formula I useful for treating hypertension or congestive heart failure and for preventing or treating restenosis following angioplasty, to pharmaceutical compositions, and to methods for production thereof.

  本发明涉及通式 I 的吡咯并嘧啶、吡啶并嘧啶、氮杂环庚并嘧啶和氮杂环辛并嘧啶。 用于治疗高血压或充血性心力衰竭以及预防或治疗血管成形术后的再狭窄、药物组合物及其生产方法。